Documentos de Académico
Documentos de Profesional
Documentos de Cultura
001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
APACHE IV Calculations
31TRGEXT000013
INSTRUCTIONS
Tab 1, p. 1 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
APACHE IV Calculations
31TRGEXT000013
Additional Notes
Tab 1, p. 2 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Tab 2, p. 3 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
<=39
40-49
50-99
100-109
110-119
120-139
140-154
>=155
8
5
0
1
5
7
13
17
Pulse points
<=39
40-59
60-69
70-79
80-99
100-119
120-129
130-139
>=140
23
15
7
6
0
4
7
9
10
MAP points
<=32.9
33-33.4
33.5-33.9
34-34.9
35-35.9
36-39.9
>=40
20
16
13
8
2
0
4
Temperature points
<=5
6-11
12-13
14-24
25-34
35-39
40-49
>=50
17
8
7
0
6
9
11
18
PaO2 (mmHg)*
*Use only for non-intubated patients or
intubated patients with FiO2 <0.5 (50%).
<=49
50-69
70-79
>=80
15
5
2
0
PaO2 points
OR
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Tab 2, p. 4 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
OR
A-aDO2*
*Only use A-aDO2 for intubated patients
with FiO2 >=0.5 (50%). Do not use PaO2
weights for these patients.
<100
100-249
250-349
350-499
>=500
0
7
9
11
14
<=40.9
41-49
>=50
3
0
3
WBC (cu/mm)
Select WBC furthest from 11.5.
<1.0
1.0-2.9
3.0-19.9
20-24.9
>=25
19
5
0
1
5
<=0.4
0.5-1.4
1.5-1.94
>=1.95
3
0
4
7
0-1.4
>=1.5
0
10
<=399
400-599
600-899
900-1499
1500-1999
2000-3999
>=4000
15
8
7
5
4
0
1
<=16.9
17-19
20-39
40-79
>=80
0
2
7
11
12
BUN points
<=119
Hematocrit (%)
Select hematocrit furthest from 45.5.
OR
Creatinine with ARF* (mg/dl)
*Acute Renal Failure (ARF) is defined as creatinine >=1.5 mg/dl
as creatinine >=1.5 mg/dl
and urine output <410 cc/day and no
chronic dialysis
Urine Output (cc/day)
Enter total for day
BUN (mg/dl)
Select highest BUN (furthest from 0)
Sodium (mEq/L)
A-aDO2 points
Hematocrit points
WBC points
OR
Sodium points
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Select Sodium furthest from 145.5.
Tab 2, p. 5 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
120-134
135-154
>=155
2
0
4
Albumin (g/dl)
Select albumin furthest from 3.5.
<=1.9
2.0-2.4
2.5-4.4
>=4.5
11
6
0
4
Albumin points
Bilirubin (mg/dl)
Select highest bilirubin (furthest from 0)
<=1.9
2.0-2.9
3.0-4.9
5.0-7.9
>=8.0
0
5
6
8
16
Bilirubin points
<=39
40-59
60-199
200-349
>=350
8
9
0
3
5
Glucose points
Glucose (mg/dl)*
Select glucose furthest from 130
*Glucose <=39 mg/dl is lower
weight than 40-59
pCO2<25 25-<30
pH <7.15
7.15-<7.2
7.20-<7.25
7.25-<7.30
7.30-<7.35
7.35-<7.40
7.40-<7.45
7.45-<7.50
7.50-<7.55
7.55-<7.60
7.60-<7.65
>=7.65
30-<35
0
35-<40 40-<45 45-<50 50-<55 55-<60 >=60
12
9
0
5
Neurological Abnormalities*
*If a patient is anesthetized, under the influence of anesthesia, or totally paralyzed/sedated during the ENTIRE data collection period,
attempt to obtain a GCS from the twelve-hour period prior to ICU admission when GCS was able to be assessed. If no assessable GCS
is documented during that time period, zero points shhould be assigned. If unable to determine verbal score (due to intubation status or
similar barriers), use clinical judgement and assign Glasgow Verbal Score according to the following scale:
1
2
12
Rev. 001
APACHE IV Calculations
Eff. Date: June 17, 2005
31TRGEXT000013
*If a patient
is anesthetized,
Owner:
Critical
Outcomes under the influence of anesthesia, or totally paralyzed/sedated during the ENTIRE data collection period,
attempt to obtain a GCS from the twelve-hour period prior to ICU admission when GCS was able to be assessed. If no assessable GCS
is documented during that time period, zero points shhould be assigned. If unable to determine verbal score (due to intubation status or
similar barriers), use clinical judgement and assign Glasgow Verbal Score according to the following scale:
alert, oriented 5
confused 3
nonresponsive 1
If patient's eyes open spontaneously (4) or to
painful/verbal stimulation (2,3), use scale:
verbal
motor
Tab 2, p. 6 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
inappropriate
words, incomp.
sounds (3,2) no response (1)
oriented,
converses (5)
obeys verbal
commands
(6)
10
15
localizes
pain (5)
13
15
flexion
withdrawal/de
corticate
rigidity (4,3)
13
24
24
decerebrate
rigidity/no
response
(2,1)
13
29
29
inappropriate
words, incomp.
sounds (3,2) no response (1)
verbal
motor
obeys verbal
commands
(6)
16
localizes
pain (5)
16
oriented,
converses (5)
flexion
withdrawal/de
corticate
rigidity (4,3)
24
33
decerebrate
rigidity/no
response (1)
29
48
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Tab 3, p. 7 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
The APACHE III Score is the sum of points assigned to Acute Physiology (the APS Score, Age, and Chronic Health.
The predictive models use each of these three components individually, as separate and distinct
variables. Therefore the APACHE III Score is not required for mortality prediction. However, some
may find it valuable for other purposes. Enter appropriate point values in the blue box to the right.
Fill in blue shaded areas to obtain APACHE III Score
Age of patient
Select one
Under age 16
<=44
45-59
60-64
65-69
70-74
75-84
>=85
AIDS
Hepatic Failure
Lymphoma
Metastatic cancer
Leukemia/multiple myeloma
Immunosuppression
Cirrhosis
None/not available
Points
do not score
0
5
11
13
16
17
24
Points
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
APACHE Disease
Mapping
AMI_ANT
AMI_INFLAT
AMI_NONQ
AMI_OTHER
CVOTH
MEDAORT
PERIART
CHESTPAIN
USTAANG
CARDARR
CARDIOMY
CVOTH
CHESTPAIN
CHESTPAIN
CHESTPAIN
CHESTPAIN
CHESTPAIN
CHFD
CVOTH
MULTRAUM
CVOTH
CVOTH
CVOTH
HEMORRHAE
HYPERT
HYPOVOLEM
CVOTH
CVOTH
CARDIOG
CVOTH
RHYTHM
RHYTHM
RHYTHM
APACHE IV Calculations
31TRGEXT000013
Cardiovascular (CARDIOVASC)
Non-Operative
Tab 4, P. 8 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
APACHE IV Calculations
Eff. Date: June 17, 2005
31TRGEXT000013
Owner: Critical Outcomes
SEPSISCUT
Sepsis, cutaneous/soft tissue
SEPSISGI
Sepsis, GI
SEPTICUT
Sepsis, gynecologic
SEPSISOTH
Sepsis, other
SEPSISPULM
Sepsis, pulmonary
SEPTICUT
Sepsis, renal/UTI (including bladder)
SEPSISUNK
Sepsis, unknown
CARDIOG
Shock, cardiogenic
CVOTH
Tamponade, pericardial
CVOTH
Thrombosis, vascular (deep vein)
PERIART
Thrombus,arterial
DRUGTOXIC
Toxicity, drug (i.e., beta blockers, calcium channel blockers, etc.)
CVOTH
Vascular medical, other
APACHE Disease
Mapping
SCARDOTH
SCARDOTH
SELAORT
SAORTDIS
SRUPAOR
SELAORT
SAORTDIS
SRUPAORT
SCARDOTH
SVALVE
SVALVE
SCARDOTH
SVHDCABG
SCABGVALV
SVHDCABG
SCABGVALV
SCABGVALV
SCABGVALV
SCARDOTH
SCARDOTH
Cardiovascular (CARDIOVASC)
Post-Operative
Ablation or mapping of cardiac conduction pathway
Aneurysm repair, ventricular
Aneurysm, abdominal aortic
Aneurysm, abdominal aortic; with dissection
Aneurysm, abdominal aortic; with rupture
Aneurysm, thoracic aortic
Aneurysm, thoracic aortic; with dissection
Aneurysm, thoracic aortic; with rupture
Aneurysms, repair of other (except ventricular)
Aortic and Mitral valve replacement
Aortic valve replacement (isolated)
Atrial Septal Defect (ASD) Repair
CABG redo with valve repair/replacement
CABG with aortic valve replacement
CABG with double valve repair/replacement
CABG with mitral valve repair
CABG with mitral valve replacement
CABG with pulmonic or tricuspid valve repair or replacement.
CABG, Minimally invasive; Mid-CABG
Cardiovascular surgery, other
Tab 4, P. 9 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
APACHE IV Calculations
Eff. Date: June 17, 2005
31TRGEXT000013
Owner: Critical Outcomes
Complications of prev. peripheral vasc. surgery,surgery for (i.e.ligation of bleeder, exploration
SCARDOTH
and evacuation of hematoma, debridement, pseudoaneurysms, clots, fistula, etc.)
Complications of previous open-heart surgery, surgery for (i.e. bleeding, infection,
SCARDOTH
mediastinal rewiring,leaking aortic graft etc.)
SCARDOTH
Congenital Defect Repair (Other)
SCARDOTH
Defibrillator, automatic implantable cardiac; insertion of
SPERISC
Dilatation (with general anesthesia)
SPERISC
Dilatation (without general anesthesia)
SPERISC
Embolectomy (with general anesthesia)
SPERISC
Embolectomy (without general anesthesia)
SCARDOTH
Endarterectomy (other vessels)
SCAROTID
Endarterectomy, carotid
SCARDOTH
Graft for dialysis, insertion of
SAGRAFT
Graft, aorto-femoral bypass
SAGRAFT
Graft, aorto-iliac bypass
SCARDOTH
Graft, femoral-femoral bypass
SFEMPGRAF
Graft, femoral-popliteal bypass
SPERISC
Grafts, all other bypass (except renal)
SPERISC
Grafts, all renal bypass
SCARDOTH
Grafts, removal of infected vascular
SVALVE
Mitral valve repair
SVALVE
Mitral valve replacement
SCARDOTH
Pericardial effusion/tamponade
SCARDOTH
Pericardiectomy (total/subtotal)
SVALVE
Pulmonary valve surgery
SPERISC
Thrombectomy (with general anesthesia)
SPERISC
Thrombectomy (without general anesthesia)
SVALVE
Tricuspid valve surgery
SCARDOTH
Tumor removal, intracardiac
SCARDOTH
Vascular surgery, other
SCARDOTH
Vena cava clipping
SCARDOTH
Vena cava filter insertion
SCARDOTH
Ventricular Septal Defect (VSD) Repair
APACHE Disease
Mapping
RENOTH
Genitourinary (GENITOURIN)
Non-Operative
Genitourinary medical, other
Tab 4, P. 10 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
CVOTH
Hemorrhage, postpartum (female only)
HEPATF
Hepato-renal syndrome
HYPERT
Pre-eclampsia/eclampsia (female only)
RENOTH
Renal bleeding
RENOTH
Renal failure, acute
RENOTH
Renal infection/abscess
RENOTH
Renal neoplasm, cancer
RENOTH
Renal obstruction
APACHE Disease
Mapping
SRENOTH
GENOTH
GENOTH
SRENOTH
SRENCA
GENOTH
GENOTH
GENOTH
GENOTH
SOBHYST
SOBHYST
GENOTH
GENOTH
GENOTH
SRENOTH
SRENCA
SRENCA
SRENOTH
SRENOTH
GENOTH
SRENOTH
GENOTH
SRENOTH
SRENCA
SRENOTH
SRENCA
APACHE IV Calculations
31TRGEXT000013
Genitourinary (GENITOURIN)
Post-Operative
Bladder repair for perforation/rupture
Cesarean section
Cyst, ruptured ovarian
Cystectomy (other reasons)
Cystectomy for neoplasm
Ectopic pregnancy (all)
Exenteration, pelvic -male
Exenteration, pelvic-female
Genitourinary surgery, other
Hysterectomy for cancer with or without lymph node dissection
Hysterectomy for other benign neoplasm/fibroids
Lymph node dissection, pelvic or retroperitoneal(female)
Lymph node dissection, pelvic or retroperitoneal(male)
Mastectomy (all)
Nephrectomy (other reasons)
Nephrectomy for neoplasm
Obstruction due to neoplasm ,surgery for; (with or without ileal-conduit)
Obstruction due to nephrolithiasis, surgery for (with or without ileal-conduit)
Obstruction/other, surgery for (with or without ileal-conduit)
Oophorectomy with/without salpingectomy with/without lymph node dissection
Orchiectomy with/without pelvic lymph node dissection
Pelvic relaxation (cystocele, rectocele, etc.)
Prostatectomy, suprapubic; for benign prostatic hypertrophy
Prostatectomy, suprapubic; for cancer
TURP, transurethral prostate resection for benign prostatic hypertrophy
TURP, transurethral prostate resection for cancer
Tab 4, P. 11 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
APACHE Disease
Mapping
OD
GIBLVAR
GIBLEED
GIBLEUL
GIBLEED
GINEOP
GINEOP
GINEOP
GINEOP
GINEOP
GIINFLA
GIINFLA
HEPATF
GIINFLA
GIOTHER
GIOBSTR
GIPERF
GIVASC
PERITOHEM
HEPATF
GIINFLA
PANCRE
GIINFLA
GIOTHER
APACHE Disease
Mapping
SGIOTH
SGIBLEE
SGIBLEE
SGIBLEE
SGIBLEE
SGICA
SGICA
SGICA
APACHE IV Calculations
31TRGEXT000013
Gastrointestinal (GI)
Non-Operative
Alcohol withdrawal
Bleeding, GI from esophageal varices/portal hpertension
Bleeding, GI-location unknown
Bleeding, lower GI
Bleeding, upper GI
Cancer, colon/rectal
Cancer, esophageal
Cancer, other GI
Cancer, pancreatic
Cancer, stomach
Cholangitis
Diverticular disease
Encephalopathy, hepatic
GI Abscess/cyst
GI medical, other
GI Obstruction
GI Perforation/rupture
GI Vascular insufficiency
Hemorrhage, intra/retroperitoneal
Hepatic failure, acute
Inflammatory bowel disease
Pancreatitis
Peritonitis
Ulcer disease, peptic
Gastrointestinal (GI)
Post-Operative
Appendectomy
Bleeding-lower GI, surgery for
Bleeding-other GI, surgery for
Bleeding-upper GI, surgery for
Bleeding-variceal, surgery for (excluding vascular shunting-see surgery for portosystemic shunt)
Cancer-colon/rectal, surgery for (including abdominoperineal resections)
Cancer-esophageal, surgery for (abdominal approach)
Cancer-other GI tract, surgery for (i.e. hepatoma, gallbladder etc.)
Tab 4, P. 12 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
Tab 4, P. 13 of 36
APACHE IV Calculations
Eff. Date: June 17, 2005
Reviewer: Fern Malila
31TRGEXT000013
Owner: Critical Outcomes
Approver: Kim Hlobik
SGICA
Cancer-small intestinal, surgery for
SGICA
Cancer-stomach, surgery for
SGIOTH
CAPD catheter insertion
SGICHOL
Cholecystectomy/cholangitis, surgery for (gallbladder removal)
SGIOTH
Complications of previous GI surgery; surgery for (anastomotic leak, bleeding, abscess, infection, dehiscence, etc.)
SGIINFL
Diverticular disease, surgery for
SGIOTH
Esophageal surgery, other
SGIABCES
Fistula/abscess, surgery for (not inflammatory bowel disease)
SGIOTH
Gastrostomy
SGIABCES
GI Abscess/cyst-primary, surgery for (for complications of GI surgery see below)
SGIOBS
GI Obstruction, surgery for (including lysis of adhesions)
SGIPERF
GI Perforation/rupture, surgery for
SGIOTH
GI surgery, other
SGIVASC
GI Vascular ischemia, surgery for (resection)
SGIOTH
Hernia-hiatal, esophageal surgery for
SGIOTH
Herniorrhaphy
SGIINFL
Inflammatory bowel disease, surgery for
SGIOTH
Obesity-morbid, surgery for
SGIOTH
Pancreatitis, surgery for
SGIOTH
Peritoneal lavage
SGIPERF
Peritonitis, surgery for
SGIOTH
Shunt, peritoneal-venous;surgery for
SGIOTH
Shunt-portosystemic, surgery for
SGIOTH
Splenectomy
SGICA
Whipple-surgery for pancreatic cancer
APACHE Disease
Mapping
HEMAMISC
HEMAMISC
COAGTHRO
HEMAMISC
HEMAMISC
HEMAMISC
HEMAMISC
HEMAMISC
HEMAMISC
Hematology (HEMATO)
Non-Operative
Anemia
Blood transfusion reaction
Coagulopathy
Hematologic medical, other
Leukemia, acute lymphocytic
Leukemia, acute myelocytic
Leukemia, chronic lymphocytic
Leukemia, chronic myelocytic
Leukemia, other
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
HEMAMISC
Lymphoma, Hodgkins
HEMAMISC
Lymphoma, non-Hodgkins
COAGTHRO
Neutropenia
COAGTHRO
Pancytopenia
HEMAMISC
Sickle cell crisis
COAGTHRO
Thrombocytopenia
APACHE Disease
Mapping
HEMAMISC
HEMAMISC
HEMAMISC
APACHE Disease
Mapping
ACIDBASE
METAMISC
GIOTHER
COMAMETU
DIABETIC
METAMISC
METAMISC
METAMISC
METAMISC
METAMISC
METAMISC
METAMISC
METAMISC
APACHE Disease
Mapping
HEMAMISC
HEMAMISC
HEMAMISC
HEMAMISC
HEMAMISC
APACHE IV Calculations
31TRGEXT000013
Hematology (HEMATO)
Post-Operative
Hematologic surgery, other
Lymphoma Hodgkins, surgery for (including staging)
Lymphoma, non-Hodgkins; surgery for (including staging)
Metabolic/Endocrine (METAB/ENDO)
Non-Operative
Acid-base electrolyte disturbance
Addisons disease
Adrenal neoplasm (including pheochromocytoma)
Diabetic hyperglycemic hyperosmolar nonketotic coma (HHNC)
Diabetic ketoacidosis
Heat exhaustion/stroke
Hyperthermia
Hyperthyroid storm/crisis
Hypoglycemia
Hypothermia
Hypothyroid/myxedema
Metabolic/endocrine medical, other
Thyroid neoplasm
Metabolic/Endocrine (METAB/ENDO)
Post-Operative
Adrenalectomy
Metabolic/endocrine surgery, other
Parathyroidectomy
Thyroidectomy and parathyroidectomy
Thyroidectomy
APACHE Disease
Mapping
GENOTH
Arthritis, rheumatoid
Musculoskeletal/Skin (MUSKELSKIN)
Non-Operative
Tab 4, P. 14 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
APACHE IV Calculations
Eff. Date: June 17, 2005
31TRGEXT000013
Owner: Critical Outcomes
GENOTH
Arthritis, septic
PERIART
Cellulitis and localized soft tissue infections
GENOTH
Connective tissue disease (mixed)
GENOTH
Lupus, systemic
GENOTH
Musculoskeletal medical, other
GENOTH
Myositis, viral
GENOTH
Rhabdomyolysis
GENOTH
Scleroderma
GENOTH
Vasculitis
APACHE Disease
Mapping
SAMPUTATE
SPERISC
GENOTH
GENOTH
GENOTH
GENOTH
GENOTH
GENOTH
GENOTH
APACHE Disease
Mapping
NEURINF
NEURMUS
COMAMETU
STROKE
OD
NEURINF
COMAMETU
NEURMUS
SAHMED
SAHMED
ICHMED
NEUROTH
NEURINF
NEURMUS
Tab 4, P. 15 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Musculoskeletal/Skin (MUSKELSKIN)
Post-Operative
Amputation (non-traumatic)
Cellulitis and localized soft tissue infections, surgery for
Cosmetic surgery (all)
Fracture-pathological, non-union, non-traumatic, for fractures due to trauma see Trauma
Grafting, skin (all)
Hip replacement, total (non-traumatic)
Knee replacement, total (non-traumatic)
Orthopedic surgery, other
Skin surgery, other
Neurologic (NEUROLOGIC)
Non-Operative
Abscess, neurologic
Amyotrophic lateral sclerosis
Coma/change in level of consciousness (for hepatic see GI, for diabetic see Endocrine, if related to cardiac arrest, see CV)
CVA, cerebrovascular accident/stroke
Drug withdrawal
Encephalitis
Encephalopathies (excluding hepatic)
Guillian-Barre syndrome
Hematoma, epidural
Hematoma, subdural
Hemorrhage/hematoma, intracranial
Hydrocephalus, obstructive
Meningitis
Myasthenia gravis
Rev. 001
APACHE IV Calculations
Eff. Date: June 17, 2005
31TRGEXT000013
Owner: Critical Outcomes
NEONEUR
Neoplasm, neurologic
NEUROTH
Neurologic medical, other
NEURMUS
Neuromuscular medical, other
CARDARR
Nontraumatic coma due to anoxia/ischemia
OD
Overdose, alcohols (bethanol, methanol, ethylene glycol)
OD
Overdose, analgesic (aspirin, acetaminophen)
OD
Overdose, antidepressants (cyclic, lithium)
OD
Overdose, other toxin, poison or drug
OD
Overdose, sedatives, hypnotics, antipsychotics, benzodiazepines
OD
Overdose, street drugs (opiates, cocaine, amphetamine)
CARDARR
Poisoning, carbon monoxide, arsenic, cyanide
SEIZ
Seizures (primary-no structural brain disease)
SAHICH
Subarachnoid hemorrhage/arteriovenous malformation
SAHICH
Subarachnoid hemorrhage/intracranial aneurysm
APACHE Disease
Mapping
SNEUROTH
SNEUROTH
SNEUROTH
SNEUROTH
SNEUROTH
SNEUROTH
SLAMINE
SNEUROTH
SNEUROTH
SLAMINE
SLAMINE
SSDH
SSDH
SICH
SLAMINE
SCRANNEO
SLAMINE
SNEUROTH
SNEUROTH
SNEUROTH
Neurologic (NEUROLOGIC)
Post-Operative
Abscess/infection-cranial, surgery for
Anastomosis, vascular
Arteriovenous malformation, surgery for
Biopsy, brain
Burr hole placement
Cerebrospinal fluid leak, surgery for
Complications of previous spinal cord surgery, surgery for
Cranial nerve, decompression/ligation
Cranioplasty and complications from previous craniotomies
Devices for spine fracture/dislocation
Fusion-spinal/Harrington rods
Hematoma, epidural, surgery for
Hematoma, subdural, surgery for
Hemorrhage/hematoma-intracranial, surgery for
Laminectomy/spinal cord decompression (excluding malignancies)
Neoplasm-cranial, surgery for (excluding transphenoidal)
Neoplasm-spinal cord surgery or other related procedures
Neurologic surgery, other
Seizures-intractable, surgery for
Shunts and revisions
Tab 4, P. 16 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
APACHE IV Calculations
Eff. Date: June 17, 2005
31TRGEXT000013
Owner: Critical Outcomes
SLAMINE
Spinal cord sugery, other
SNEUROTH
Stereotactic procedure
SSAH
Subarachnoid hemorrhage/intracranial aneurysm, surgery for
SLAMINE
Sympathectomy
SCRANNEO
Transphenoidal surgery
SNEUROTH
Ventriculostomy
APACHE Disease
Mapping
RESPOTH
PULEDEM
RESPARR
ALLERGY
RESPOTH
RESPCA
RESPCA
RESPCA
RESPCA
PLEUREFFUS
PULEMB
COPD
RESPOTH
RESPOTH
RESPOTH
RESPOTH
AIROBS
ASPPNEU
BACPNEU
PARAPNEU
BACPNEU
PARAPNEU
BACVPNEU
RESPOTH
RESPOTH
RESLUNGDIS
RESPOTH
RESPOTH
Respiratory (RESPIRAT)
Non-Operative
Apnea, sleep
ARDS-adult respiratory distress syndrome, non-cardiogenic pulmonary edema
Arrest, respiratory (without cardiac arrest)
Asthma
Atelectasis
Cancer, laryngeal
Cancer, lung
Cancer, oral
Cancer, tracheal
Effusions, pleural
Embolus, pulmonary
Emphysema/bronchitis
Hemorrhage/hemoptysis, pulmonary
Hemothorax
Hypertension-pulmonary, primary/idiopathic
Near drowning accident
Obstruction-airway (i.e. acute epiglottitis, post-extubation edema, foreign body, etc.)
Pneumonia, aspiration
Pneumonia, bacterial
Pneumonia, fungal
Pneumonia, other
Pneumonia, parasitic (i.e. Pneumocystis pneumonia)
Pneumonia, viral
Pneumothorax
Respiratory- medical, other
Restrictive lung disease (i.e. sarcoidosis, pulmonary fibrosis)
Smoke inhalation
Weaning from mechanical ventilation (transfer from other unit or hospital only)
Tab 4, P. 17 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
APACHE Disease
Mapping
SRESTOTH
SLUNG
SRESOTH
SRESPLAR
SRESPLAR
SRESOTH
SRESPINF
SRESOTH
SRESPCA
SRESOTH
SGICA
SRESPCA
SRESOTH
SRESPCA
SRESOTH
SLUNG
SRESPINF
SRESOTH
APACHE IV Calculations
31TRGEXT000013
Respiratory (RESPIRAT)
Post-Operative
Apnea-sleep; surgery for (i.e. UPPP -uvulopalatopharyngoplasty)
Biopsy, open lung
Bullectomy
Cancer oral/sinus, surgery for
Cancer-laryngeal/tracheal, surgery for
Facial surgery (if related to trauma, see Trauma)
Infection/abscess, other surgery for
Respiratory surgery, other
Thoracotomy for benign tumor (i.e. mediastinal chest wall mass, thymectomy
Thoracotomy for bronchopleural fistula
Thoracotomy for esophageal cancer
Thoracotomy for lung cancer
Thoracotomy for lung reduction
Thoracotomy for other malignancy in chest
Thoracotomy for other reasons
Thoracotomy for pleural disease
Thoracotomy for thoracic/respiratory infection
Tracheostomy
APACHE Disease
Transplant (TRANSPLANT)
Mapping
Non-Operative
RENOTH
Kidney transplant
HEPATF
Liver transplant
NON-PREDICTIVE ALL OTHER NON_OPERATIVE TRANSPLANTS
APACHE Disease
Transplant (TRANSPLANT)
Mapping
Post-Operative
SRENTRAN
Kidney transplant
SLIVERTR
Liver transplant
NON-PREDICTIVE ALL OTHER POST-OPERATIVE TRANSPLANTS
APACHE Disease
Mapping
MULTRAUM
MULTRAUM
MULTRAUM
MULTRAUM
Trauma (TRAUMA)
Non-Operative
Abdomen only trauma
Abdomen/extremity trauma
Abdomen/face trauma
Abdomen/multiple trauma
Tab 4, P. 18 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
MULTRAUM
Abdomen/pelvis trauma
MULTRAUM
Abdomen/spinal trauma
MULTRAUM
Chest/abdomen trauma
MULTRAUM
Chest/extremity trauma
MULTRAUM
Chest/face trauma
TRAUMCHSP
Chest/multiple trauma
MULTRAUM
Chest/pelvis trauma
TRAUMCHSP
Chest/spinal trauma
MULTRAUM
Chest/thorax only trauma
MULTRAUM
Extremity only trauma
MULTRAUM
Extremity/face trauma
MULTRAUM
Extremity/multiple trauma
MULTRAUM
Face only trauma
MULTRAUM
Face/multiple trauma
TRHEADONLY
Head (CNS) only trauma
HEADTR
Head/abdomen trauma
HEADTR
Head/chest trauma
TRHEADEXF
Head/extremity trauma
TRHEADEXF
Head/face trauma
TRHEADMULT
Head/multiple trauma
HEADTR
Head/pelvis trauma
HEADTR
Head/spinal trauma
MULTRAUM
Pelvis/extremity trauma
MULTRAUM
Pelvis/face trauma
MULTRAUM
Pelvis/hip only trauma
MULTRAUM
Pelvis/multiple trauma
MULTRAUM
Pelvis/spinal trauma
TRAUMSPINE
Spinal cord only trauma
MULTRAUM
Spinal/extremity trauma
MULTRAUM
Spinal/face trauma
MULTRAUM
Spinal/multiple trauma
MULTRAUM
Trauma medical, other
APACHE Disease
Mapping
SMULTR
Abdomen only trauma, surgery for
SMULTR
Abdomen/extremity trauma, surgery for
APACHE IV Calculations
31TRGEXT000013
Trauma (TRAUMA)
Post-Operative
Tab 4, P. 19 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
SMULTR
Abdomen/face trauma, surgery for
SMULTR
Abdomen/multiple trauma, surgery for
SMULTR
Abdomen/pelvis trauma, surgery for
SMULTR
Abdomen/spinal trauma, surgery for
SMULTR
Chest/abdomen trauma, surgery for
SMULTR
Chest/extremity trauma, surgery for
SMULTR
Chest/face trauma, surgery for
SMULTR
Chest/multiple trauma, surgery for
SMULTR
Chest/pelvis trauma, surgery for
SMULTR
Chest/spinal trauma, surgery for
SMULTR
Chest/thorax only trauma, surgery for
STRAUMEXT
Extremity only trauma, surgery for
SMULTR
Extremity/face trauma, surgery for
SMULTR
Extremity/multiple trauma, surgery for
SMULTR
Face only trauma, surgery for
SMULTR
Face/multiple trauma, surgery for
STRHDONLY
Head (CNS) only trauma, surgery for
SHEADTR
Head/abdomen trauma, surgery for
SHEADTR
Head/chest trauma, surgery for
SHEADTR
Head/extremity trauma, surgery for
SHEADTR
Head/face trauma, surgery for
SHEADTR
Head/multiple trauma, surgery for
SHEADTR
Head/pelvis trauma, surgery for
SHEADTR
Head/spinal trauma, surgery for
SMULTR
Pelvis/extremity trauma, surgery for
SMULTR
Pelvis/face trauma, surgery for
SMULTR
Pelvis/hip only trauma,surgery for
SMULTR
Pelvis/multiple trauma, surgery for
SMULTR
Pelvis/spinal trauma, surgery for
SMULTR
Spinal cord only trauma, surgery for
SMULTR
Spinal/extremity trauma, surgery for
SMULTR
Spinal/face trauma, surgery for
SMULTR
Spinal/multiple trauma, surgery for
SMULTR
Trauma surgery, other
APACHE IV Calculations
31TRGEXT000013
Tab 4, P. 20 of 36
Reviewer: Fern Malila
Approver: Kim Hlobik
Rev. 001
Eff. Date: June 17, 2005
Owener: Critical Outcomes
Tab 5, p. 21 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
Age
AGE1
AGE2
AGE3
AGE4
AGE5
Coefficient
Knot Points Cross Product
-5.950471952
-5.9504719516
0.0241774552
0
-4.3886E-006
27
0
5.01422E-005
51
0
-0.000127787
64
0
0.000109606
74
0
-2.7572E-005
86
0
0
0
0
0
0
0
0
0
0.9581005157
1.0373799253
0.743471748
1.0864237522
0.9693082989
0.4355810827
0.8146650877
0
Acute Physiology Score
Enter the Acute Physiology
Score. Splining of this variable
will autocalculate APS3ALL
APS
APS3ALL1
APS3ALL2
APS3ALL3
APS3ALL4
APS3ALL5
0 0.0556349159
0 8.71852E-006
0 -4.5110E-005
0.00005038
0
0 -1.3123E-005
0 -8.6535E-007
-0.000397068
PA/FI Ratio
10
22
32
48
89
0
0
0
0
0
0
0
1=Yes
0.2717600356
0.0171491928
0.0221062655
-0.583828121
0
0
Rev. 001
Eff. Date: June 17, 2005
Owener: Critical Outcomes
Emergency Surgery
Admitting Diagnosis*
*See mapping table
*Select only one
Tab 5, p. 22 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
0.2490734585
0/1
# Days between ICU
and Hosp Admission
square root of days (aut
PRELOS21
PRELOS22
PRELOS23
PRELOS24
ACIDBASE
AIROBS
ALLERGY
AMI_ANT
AMI_INFRLATR
AMI_NONQ
ASPPNEU
BACPNEU
BACVPNEU
CARDARR
CARDIOG
CARDIOMY
CHESTPAIN
CHFD
COAGTHRO
COMAMETU
COPDD
CVOTH
DIABETIC
DRUGTOXIC
GENOTH
GIBLEED
0
0
0
0
0
-0.310487496
1.4746725115
-2.8618857
1.4216590103
-0.034445822
-0.640575517
-0.977669154
-1.540678498
0.1029497654
-0.152525079
-0.270872458
-0.37223658
-0.043365914
0.2543749044
0.4169191406
0.2397114719
0.0599624438
-1.122354572
-0.422587793
0.2581724351
-0.927156778
-0.398697453
-0.369658509
-1.775702142
-0.690943246
-0.667576408
-0.551832894
0.121
0.423
0.794
2.806
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Rev. 001
Eff. Date: June 17, 2005
Owener: Critical Outcomes
Tab 5, p. 23 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
GIBLEUL
GIBLVAR
GIINFLA
GINEOP
GIOBSTR
GIOTHER
GIPERF
GIVASC
HEADTR
HEMAMISC
HEMORRHAGE
HEPATF
HYPERT
HYPOVOLEM
ICHMED
MEDAORT
METAMISC
MULTRAUM
NEONEUR
NEURINF
NEURMUS
NEUROTH
OD
PANCRE
PARAPNEU
PERIART
PERITOHEM
PLEUREFFUS
PULEDEM
PULEMB
RENOTH
RESLUNGDIS
-0.579471867
-0.527719358
-0.211771894
0.1951302908
-0.369945003
-0.252586643
-0.327171182
0.714879336
-0.372350315
-0.342352862
-0.656757432
-0.119675791
-0.813921325
-0.622592285
0.9450561547
0.6491493051
-0.986438209
-0.678110274
0.0189527274
-0.535783229
-0.550653067
-0.176828697
-1.55261952
-0.513627563
1.0561873472
-0.502752032
-0.659544401
0.1899005237
-0.2416873
-0.051527401
-0.54158014
1.5552965796
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Rev. 001
Eff. Date: June 17, 2005
Owener: Critical Outcomes
Tab 5, p. 24 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
RESPARR
RESPCA
RESPOTH
RHYTHM
SAGRAFT
SAHICH
SAHMED
SAMPUTATE
SAORTDIS
SCABGVALV
SCARDOTH
SCAROTID
SCRANNEO
SEIZ
SELAORT
SEPSISCUT
SEPSISGI
SEPSISOTH
SEPSISPULM
SEPSISUNK
SEPTICUT
SFEMPGRAF
SGIABCES
SGIBLEE
SGICA
SGICHOL
SGIINFL
SGIOBS
SGIOTH
SGIPERF
SGIVASC
SHEADTR
-0.390631425
0.966313802
-0.202823617
-0.603060945
-0.831194514
0.6159503846
0.2950939014
0.604910303
-0.178456475
-1.199434806
-0.59044574
-1.332642438
-0.437737676
-0.942170992
-0.760703396
0.1264403154
-0.13010935
-0.04233671
-0.258766455
-0.093377498
-0.732788506
-0.786571016
-0.556661177
-0.329679773
0.1362826618
-0.593293673
-0.165585527
-0.189005132
-0.295894316
-0.189960264
0.4983280142
0.3577977348
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Rev. 001
Eff. Date: June 17, 2005
Owener: Critical Outcomes
SICH
SLAMINE
SLIVERTR
SLUNG
SMULTR
SNEUROTH
SOBHYST
SPERISC
SRENCA
SRENOTH
SRENTRAN
SRESOTH
SRESPCA
SRESPINF
SRESPLAR
SRUPAOR
SSAH
SSDH
STRAUMEXT
STRHDONLY
STROKE
SVALVE
SVHDCABG
TRAUMCHSP
TRAUMSPINE
TRHEADEXF
TRHEADMULT
TRHEADONLY
USTAANG
0.5267174102
-0.628609547
-1.370278559
0.4057380077
-0.377807998
0.0039963394
-0.795847883
-0.504208244
-1.397212695
-0.693574061
-1.308449407
-0.249217228
0.086933576
-0.005937516
-1.152870135
0.204404736
0.318905704
0.7156826217
-0.180386981
1.0888193243
0.5194530354
-1.371763972
-0.155141644
-0.717432122
0.0337694835
-0.364128015
-0.067960926
0.5958694161
-1.212730735
0
IF diagnosis is ACUTEMI
Tab 5, p. 25 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
Thrombolytic Therapy
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.579874039
Rev. 001
Eff. Date: June 17, 2005
Owener: Critical Outcomes
(Unable = 1)
GCS
Prediction = x/(1+x)
Tab 5, p. 26 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
0.7857643165
0 0.0391175318
-5.9504719516
0.002604611
0.26%
Note: Predictions after the initial day contain an additional variable that updates the patient's APACHE III score for changes in physiological status,
and the relative contributions of age and comorbidities are also different on subsequent days. These equations are intended to be used to generate
hospital mortality prediction on Day 1 of the patient's ICU stay ONLY. Using these coefficients for other days is inappropriate and will yield erroneous
predictions.
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
HOSPITAL MORTALITY-CABG Only
Tab 6, p.27 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
CABG Patient Only
Intercept
<45
45-54
55-59
60-64
65-69
70-74
75-84
>=85
Chronic Health
APS
EQ18_APS3ALL1
EQ18_APS3ALL2
EQ18_APS3ALL3
EQ18_APS3ALL4
kd
diff
Emergency Surgery
CABG-Specific Variables
Enter all that apply
Value
1
Coefficient
Knot PointCross Product
-7.246664
-7.246664
0
0
0
-0.737078
-0.765009
-0.529345
-0.222009
0.107859
0.169567
0.765707
0
0
0
0
0
0
0
0
0
0
0
0
0
17.784467
30
0.044207
0.17313
-0.041316
-1.145473
1.713847
0/1
0.76644
Female (yes=1)
Redo CABG (yes=1)
Number of grafts
0.861304
1.206335
0.082575
0
0
0
15
30
40
50
60
90
0
0
0
0
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Sum of cross products
Natural antilog of sum =x
Prediction = x/(1+x)
Tab 6, p.28 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
-7.246664
0.00071255
0.07%
Note: Predictions after the initial day contain an additional variable that updates the patient's APACHE III score for changes in physiological status,
and the relative contributions of age and comorbidities are also different on subsequent days. This equation is intended to be used to generate
hospital mortality prediction on Day 1 of the patient's ICU stay ONLY. Using these coefficients for other days is inappropriate and will yield erroneous
predictions.
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
APACHE IV ICU LENGTH OF STAY
Intercept
Age (0/1) Select one
Tab 7, p. 29 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
NON CABG Patient Only
Value
Age
AGE1
AGE2
AGE3
AGE4
AGE5
Coefficient
Knot Points Cross Product
1 1.6738879246
1.6738879246
0.0176033952
0
27
0 -7.6826E-006
0
51
0 3.95667E-005
0
64
0 -0.000166793
0
74
0 0.0002281564
0
86
0 -9.3248E-005
0
0
-0.10285942
-0.16012995
-0.28079854
-0.491932974
-0.803754341
-0.07438064
0.3626586131
0
0
0
0
0
0
0
0
0
Acute Physiology Score
Enter the Acute Physiology
Score. Splining of this variable
will autocalculate APS3ALL
APS
APS3ALL1
APS3ALL2
APS3ALL3
APS3ALL4
APS3ALL5
PaO2/FIO2 Ratio
0.0444269895
0 -5.8305E-005
0 0.0002970084
0 -0.000404434
0 0.0001892508
0 -2.3520E-005
10
22
32
48
89
0
0
0
0
0
0
-0.004581842
1=Yes
1.8353095408
0.0065293818
0.8555050425
-0.599591763
0
0
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Tab 7, p. 30 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
0
Readmit
0/1
0.5403684594
Emergency Surgery
0/1
1.0406906318
0.4598231293
0.3977919374
-0.945210953
0.5886512665
-0.041232251
0
0
0
0
0
0
Admitting Diagnosis*
*See mapping table
*Select only one
0
0
0
0
0
-0.382017407
0.3471484637
-0.542185912
0.0857685121
-0.036016015
-0.057916835
0.8602584271
1.3067446009
1.1560647567
-0.751470488
0.3299898856
0.5570053879
-0.520128136
-0.219091549
0.3998174157
-0.081962609
-0.446092483
-0.132883369
-0.58421484
-0.882634505
0.121
0.423
0.794
2.806
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Tab 7, p. 31 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
GENOTH
GIBLEED
GIBLEUL
GIBLVAR
GIINFLA
GINEOP
GIOBSTR
GIOTHER
GIPERF
GIVASC
HEADTR
HEMAMISC
HEMORRHAGE
HEPATF
HYPERT
HYPOVOLEM
ICHMED
MEDAORT
METAMISC
MULTRAUM
NEONEUR
NEURINF
NEURMUS
NEUROTH
OD
PANCRE
PARAPNEU
PERIART
PERITOHEM
PLEUREFFUS
PULEDEM
PULEMB
-0.420843422
0.0213604052
0.1856965939
-0.083385343
0.532982522
1.3368312875
2.0686144603
0.5565887447
2.2086995672
1.9440608345
2.1289081715
-0.126173954
-0.381155309
0.1949458349
-0.067961418
-0.389881468
0.8632948203
1.3106215068
-0.363969853
1.5211879362
0.9748471868
1.1655653196
3.9256604297
0.3575043808
-0.89006849
2.7626886748
1.6197005464
0.8443265288
0.1652656354
0.8100930286
1.4427509398
0.1068340489
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Tab 7, p. 32 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
RENOTH
RESLUNGDIS
RESPARR
RESPCA
RESPOTH
RHYTHM
SAGRAFT
SAHICH
SAHMED
SAMPUTATE
SAORTDIS
SCABGVALV
SCARDOTH
SCAROTID
SCRANNEO
SEIZ
SELAORT
SEPSISCUT
SEPSISGI
SEPSISOTH
SEPSISPULM
SEPSISUNK
SEPTICUT
SFEMPGRAF
SGIABCES
SGIBLEE
SGICA
SGICHOL
SGIINFL
SGIOBS
SGIOTH
SGIPERF
-0.152233731
1.024903996
-0.053291846
-0.140474342
0.2404909089
-0.302546395
0.5239223901
3.0086087597
1.1953150967
-0.325703861
1.1100214568
-1.358289429
-1.28358348
-0.14649332
0.319065119
-0.330810671
0.7739464631
1.5642195701
1.2453136733
0.6490771069
1.9266479992
0.4025902569
0.4531372416
-0.204188913
0.7199377967
-0.045403893
0.3248658754
-0.588512311
0.6869364416
0.1873047354
0.2170447191
1.0553746251
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Tab 7, p. 33 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
SGIVASC
SHEADTR
SICH
SLAMINE
SLIVERTR
SLUNG
SMULTR
SNEUROTH
SOBHYST
SPERISC
SRENCA
SRENOTH
SRENTRAN
SRESOTH
SRESPCA
SRESPINF
SRESPLAR
SRUPAOR
SSAH
SSDH
STRAUMEXT
STRHDONLY
STROKE
SVALVE
SVHDCABG
TRAUMCHSP
TRAUMSPINE
TRHEADEXF
TRHEADMULT
TRHEADONLY
USTAANG
0.6206952495
3.20631279
2.9498695693
-0.251392367
-0.848656603
0.1859748668
1.4854303079
0.5513312249
-0.162493249
0.1022934618
-0.423760975
-0.58901834
-0.556650506
-0.359443815
0.1999254548
0.044451048
-0.053892181
2.7766388797
2.599592539
1.3423449617
-0.481004907
2.1021826433
0.3132337931
-2.076438218
-0.332456954
2.574268317
2.1681426709
0.8600333425
3.6375602953
0.834081141
-0.368981979
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Tab 7, p. 34 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
IF diagnosis is ACUTEMI
Thrombolytic Therapy
(Unable = 1)
0.062385214
1.7893266131
0 -0.015182904
Prediction (days)
Note: Length of Stay predictions are intended to be used to generate ICU length of stay predictions on
Day 1 of the patient's stay ONLY.
Using these coefficients for other days is inappropriate and will yield erroneous predictions.
1.6738879246
1.67
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
ICU Length of Stay-CABG ONLY
Age (0/1) Select one
Tab 8, p. 35 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
CABG Patient Only
Intercept
AGE
EQ18_AGE1
EQ18_AGE2
EQ18_AGE3
EQ18_AGE4
EQ18_AGE5
Value
Chronic Health
(yes=1)
0 0.159896
APS
EQ18_APS3ALL1
EQ18_APS3ALL2
EQ18_APS3ALL3
EQ18_APS3ALL4
EQ18_APS3ALL5
0
0
0
0
0
Emergency Surgery
0/1
0 0.284642
Creatinine
CREA
EQ18_CREA1
EQ18_CREA2
EQ18_CREA3
EQ18_CREA4
EQ18_CREA5
0
0
0
0
0
-0.02843
0.000126
-0.000295
0.000167
-1.04E-06
2.85E-06
-0.004945
-3.581329
21.94124
-608.0213
591.272
-1.610631
15
25
32
40
61
0
0
0
0
0
0
0
0.6
0.8
1.09
1.1
1.9
0
0
0
0
0
0
Rev. 001
Eff. Date: June 17, 2005
Owner: Critical Outcomes
Tab 8, p. 36 of 36
Reviewed by: Fern Malila
Approved by: Kim Hlobik
APACHE IV Calculations
31TRGEXT000013
Ejection Fraction
PLVEJECT
EQ18_PLVEJECT1
EQ18_PLVEJECT2
EQ18_PLVEJECT3
EQ18_PLVEJECT4
EQ18_PLVEJECT5
0
0
0
0
0
0
-0.005927
-7.65E-06
20
0.000136
45
-0.000334 54.21552
0.000211
60
5.06E-06
99
CABG-Specific Variables
Enter all that apply
Female (yes=1)
Redo CABG (yes=1)
IMA used (yes=1)
MIDUR (yes=1)
Number of grafts = 2
Number of grafts = 3
Number of grafts = 4
Number of grafts = 5
Number of grafts = 6
Number of grafts >=7
0.278597
0.336221
-0.197821
0.214881
0.052944
0.111277
-0.053388
-0.233051
-0.437164
0 -0.482726
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Sum of cross products
Prediction =
2.004583
2.00
Note: Predictions after the initial day contain an additional variable that updates the patient's APACHE III score for changes in physiological status,
and the relative contributions of age and comorbidities are also different on subsequent days. This equation is intended to be used to generate
hospital mortality prediction on Day 1 of the patient's ICU stay ONLY. Using these coefficients for other days is inappropriate